Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H23NO |
| Molecular Weight | 245.3599 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1(C2CCCC1CN(C)C2)C3=CC=CC=C3
InChI
InChIKey=YFFNPIAPUDUYAU-UHFFFAOYSA-N
InChI=1S/C16H23NO/c1-17-11-14-9-6-10-15(12-17)16(14,18-2)13-7-4-3-5-8-13/h3-5,7-8,14-15H,6,9-12H2,1-2H3
| Molecular Formula | C16H23NO |
| Molecular Weight | 245.3599 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Azabicyclane (azabicyclane) is an analgesic and antiinflammatory agent. The analgesic effect of azabicyclane has been demonstrated in mice and rats in tests using mechanical, chemical and thermal stimuli. The analgesic potency of azabicyclane was about 3-6 times greater than that of meperidine according to these testing methods.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5528556
In rats treated with 8 mg/kg, 3 times daily,
azabicyclane induced no significant loss of body weight during the withdrawal period.
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:03:10 GMT 2025
by
admin
on
Mon Mar 31 18:03:10 GMT 2025
|
| Record UNII |
K2S5VMM2SG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
15378-99-1
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
27213
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
DTXSID501043117
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
K2S5VMM2SG
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
3399
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
SUB05504MIG
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105792
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
100000086940
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY | |||
|
C77276
Created by
admin on Mon Mar 31 18:03:10 GMT 2025 , Edited by admin on Mon Mar 31 18:03:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |